Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/16/1999 | US5871735 Isoferritin as a marker for pathological pregnancy |
02/16/1999 | US5871732 Dna sequences and genetic engineering for aids |
02/16/1999 | US5871712 Neurodegenerative condition, antiischemic agents and antibodies |
02/16/1999 | US5871695 A gelatinous reagent containing chlorid ions, aliphatic alcohol, iron3+ and trace amount of selected agents is useful for detecting atherogenic metabolism and bilirubinemia by colorimetric or spectrometric analysis of body fluid |
02/16/1999 | US5871432 Method and apparatus for making an improved resilient packing product |
02/16/1999 | CA2172343C Culture slide assembly |
02/16/1999 | CA2122112C Adrenomedullin |
02/16/1999 | CA2021312C Analyzer unit for heterogeneous immunological tests |
02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
02/16/1999 | CA1340396C Functionalized conductive polymers and their use in diagnostic devices |
02/16/1999 | CA1340395C Analysis of ions present at low concentrations in solutions with other at higher concentrations |
02/16/1999 | CA1340393C Production of recombinant human psti in saccharomyces cerevisiae |
02/16/1999 | CA1340391C Monoclonal antibodies against atrial, natriuretic peptides of humans |
02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
02/14/1999 | CA2239264A1 Novel uses |
02/13/1999 | CA2240637A1 Novel ratb |
02/13/1999 | CA2240627A1 Novel ratc |
02/13/1999 | CA2240623A1 Novel rata |
02/13/1999 | CA2234415A1 A method of identifying agonist and antagonists for tumor necrosis related receptors tr1 and tr2 |
02/12/1999 | CA2239837A1 Novel murd |
02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
02/12/1999 | CA2239819A1 Ftsz |
02/12/1999 | CA2231728A1 Mray |
02/11/1999 | WO1999006840A1 Collagen-peptide assay method |
02/11/1999 | WO1999006839A1 Method of identifying and developing drug leads |
02/11/1999 | WO1999006838A2 Novel method of detecting amyloid-like fibrils or protein aggregates |
02/11/1999 | WO1999006837A1 Method for detecting hbcag from hepatitis b virus |
02/11/1999 | WO1999006836A1 Methods for detecting or assaying virus |
02/11/1999 | WO1999006835A1 Regenerable biosensor using total internal reflection fluorescence with electrochemical control |
02/11/1999 | WO1999006834A2 Methods for identifying ligand specific binding molecules |
02/11/1999 | WO1999006832A1 Method for the specific detection or diagnosis of primary infection and reagent kits usable therein |
02/11/1999 | WO1999006831A2 Breast cancer resistance genes, methods for their detection and uses thereof |
02/11/1999 | WO1999006830A1 Method for modulating g-protein coupled receptors |
02/11/1999 | WO1999006829A1 Blood diluent |
02/11/1999 | WO1999006828A1 Cancer detection by centrosome abnormality |
02/11/1999 | WO1999006825A1 Low-cost multilaminate sensors |
02/11/1999 | WO1999006811A2 Method for counting dendritic cells |
02/11/1999 | WO1999006599A1 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |
02/11/1999 | WO1999006597A1 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
02/11/1999 | WO1999006596A1 Nucleic acid probes for detecting candida species |
02/11/1999 | WO1999006593A1 Solid support with attached molecules |
02/11/1999 | WO1999006592A1 Separation of nucleic acids by antibodies to halogenated nucleotides |
02/11/1999 | WO1999006588A1 A cell-free system of mitochondria-dependent apoptosis, and methods of use thereof |
02/11/1999 | WO1999006587A2 Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex |
02/11/1999 | WO1999006577A2 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide |
02/11/1999 | WO1999006575A1 Starch debranching enzymes |
02/11/1999 | WO1999006559A1 Methods to identify growth differentiation factor (gdf) receptors |
02/11/1999 | WO1999006558A1 Human longevity-assurance protein homologs |
02/11/1999 | WO1999006557A2 Mammalian cell membrane proteins; related reagents |
02/11/1999 | WO1999006551A2 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
02/11/1999 | WO1999006549A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
02/11/1999 | WO1999006545A2 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
02/11/1999 | WO1999006543A1 Assays for compounds which extend life span |
02/11/1999 | WO1999006541A1 Antihuman pre-b cell receptor antibodies |
02/11/1999 | WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
02/11/1999 | WO1999006535A1 Screening assays for g protein coupled receptor agonists and antagonists |
02/11/1999 | WO1999006534A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
02/11/1999 | WO1999006445A1 Growth differentiation factor-15 |
02/11/1999 | WO1999006443A1 Growth differentiation factor, lefty-2 |
02/11/1999 | WO1999006440A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
02/11/1999 | WO1999006428A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
02/11/1999 | WO1999006427A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
02/11/1999 | WO1999006426A1 Novel molecules of the tango-77 related protein family and uses thereof |
02/11/1999 | WO1999006425A1 Oxidized styrenic polymers for dna binding |
02/11/1999 | WO1999006422A2 Base analogues |
02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
02/11/1999 | WO1999006074A1 Use of texaphyrins in detection of melanin and melanin metabolites of melanotic melanoma |
02/11/1999 | WO1999006068A2 Recombinant dimeric envelope vaccine against flaviviral infection |
02/11/1999 | WO1999006059A2 Methods and compositions relating to no-mediated cytotoxicity |
02/11/1999 | WO1999005916A1 Method for evaluating half-carcasses by means of optical image processing |
02/11/1999 | WO1998050556A3 Intracellular production of hepatitis c e1 and e2 truncated polypeptides |
02/11/1999 | WO1998047000A3 Process and reagent for eliciting a target biological material |
02/11/1999 | WO1998046984A3 Methods and systems for sensing water in liquids |
02/11/1999 | WO1998035012A3 Methods and products for analyzing polymers |
02/11/1999 | WO1998020354A3 Monitoring reactivity of thyroid peroxidase autoantibodies |
02/11/1999 | DE19734135A1 System zum Zurverfügungstellen biologischer Materialien A system for providing biological materials |
02/11/1999 | DE19733389A1 Mittel zur Expression und zum Nachweis eines ein HPOL-Epitop und ein Polypeptid umfassenden Fusionspolypeptids Means for expression and detection of a HPOL epitope and a polypeptide comprising the fusion polypeptide |
02/11/1999 | DE19730497A1 Magnetstift zur Konzentrierung und Separierung von Partikeln Magnetic pin for the concentration and separation of particles |
02/11/1999 | DE19730132A1 Detecting organisms causing spongiform encephalopathy |
02/11/1999 | DE19729591A1 Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen Agents for the treatment and / or prophylaxis of microcirculation disorders |
02/11/1999 | DE19728737C1 Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten A method for the detection and determination of GnRH receptors and the use of GnRH agonists and GnRH-antagonists for the treatment of a tumor originating in the brain and / or nervous system and / or the meninges |
02/11/1999 | CA2493240A1 Methods for detecting or assaying virus |
02/11/1999 | CA2300336A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization |
02/11/1999 | CA2299276A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
02/11/1999 | CA2299256A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
02/11/1999 | CA2299055A1 Novel molecules of the tango-77 related protein family and uses thereof |
02/11/1999 | CA2298766A1 Human longevity-assurance protein homologs |
02/11/1999 | CA2298629A1 Method of identifying and developing drug leads |
02/11/1999 | CA2298538A1 Recombinant dimeric envelope vaccine against flaviviral infection |
02/11/1999 | CA2298102A1 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
02/11/1999 | CA2298101A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
02/11/1999 | CA2297776A1 Base analogues |
02/11/1999 | CA2297745A1 Oxidized styrenic polymers for dna binding |
02/11/1999 | CA2297555A1 Collagen-peptide assay method |
02/11/1999 | CA2297157A1 5' ests for secreted proteins expressed in testis and other tissues |
02/11/1999 | CA2297070A1 Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex |
02/11/1999 | CA2296809A1 5' ests for secreted proteins identified from brain tissues |
02/11/1999 | CA2296038A1 Solid support with attached molecules |
02/11/1999 | CA2294650A1 Starch debranching enzymes |